Annette Snejbjerg Bartels

Annette Snejbjerg Bartels

Biomedical Laboratory Scientist


Publication year:
All
1 - 10 out of 15Page size: 10
Sort by: Title
  1. Published

    The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells

    Høeberg, M., Noer, Julie Boertmann, Vistesen, M. V., Bartels, Annette Snejbjerg, Bech, E. M., Nygård, S. B., Lademann, U., Stenvang, Jan, Liu, S., Fuglsang, Anja Thoe, Brünner, N. & Moreira, José, 2023, In: Molecular Oncology. 17, 8, p. 1595-1612

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients

    Hertel, P. B., Tu, D., Ejlertsen, Bent Laursen, Jensen, M. R., Balslev, E., Jiang, S., O'Malley, F. P., Pritchard, K. I., Shepherd, L. E., Bartels, Annette Snejbjerg, Brunner, N. & Nielsen, T. O., 2012, In: Breast Cancer Research and Treatment. 132, 1, p. 225-234 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

    Jørgensen, C. L. T., Bjerre, C. A., Ejlertsen, Bent Laursen, Bjerre, K. D., Balslev, E., Bartels, Annette Snejbjerg, Brünner, N. & Nielsen, D. L., 2014, In: B M C Cancer. 14, 14 p., 360.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Proteomic Profiling of Colorectal Adenomas Identifies a Predictive Risk Signature for Development of Metachronous Advanced Colorectal Neoplasia

    Bech, J. M., Terkelsen, Thilde Bagger, Bartels, Annette Snejbjerg, Coscia, F., Doll, S., Zhao, S., Zhang, Z., Brünner, N., Lindebjerg, J., Madsen, G. I., Fang, X., Mann, Matthias & Moreira, José, 2023, In: Gastroenterology. 165, 1, p. 121-132.e5

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial

    Erber, R., Gluz, O., Brünner, N., Kreipe, H. H., Pelz, E., Kates, R., Bartels, Annette Snejbjerg, Huober, J., Mohrmann, S., Moustafa, Z., Liedtke, C., Möbus, V., Augustin, D., Thomssen, C., Jänicke, F., Kiechle, M., Kuhn, W., Nitz, U., Harbeck, N. & Hartmann, A., Apr 2015, In: Breast Cancer Research and Treatment. 150, 2, p. 279-288 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    PPARa and PPAR¿ coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats

    Egerod, F. L., Svendsen, J. E., Hinley, J., Southgate, J., Bartels, Annette Snejbjerg, Brünner, N. & Oleksiewicz, M. B., 2009, In: Toxicologic Pathology. 37, 7, p. 947-958 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival

    Aaberg-Jessen, C., Christensen, K., Offenberg, H. K., Bartels, Annette Snejbjerg, Dreehsen, T., Hansen, S., Schrøder, H. D., Brunner, N. & Kristensen, B. W., 2009, In: Journal of Neuro-Oncology. 95, 1, p. 117-128 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer

    Steffensen, K. D., Waldstrøm, M., Christensen, R. K., Bartels, Annette Snejbjerg, Brunner, N. & Jakobsen, A., 2010, In: BMC Cancer. 10, 185, 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer: A Danish Breast Cancer Cooperative Group Study

    Willemoe, G. L., Hertel, P. B., Bartels, Annette Snejbjerg, Jensen, M., Balslev, E., Rasmussen, B. B., Mouridsen, H. T., Ejlertsen, Bent Laursen & Brunner, N., 2009, In: European Journal of Cancer. 45, 14, p. 2528-2536 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?

    Munro, A. F., Bartels, Annette Snejbjerg, Balslev, E., Twelves, C. J., Cameron, D. A., Brünner, N. & Bartlett, J. M., 2013, In: Breast Cancer Research (Online Edition). 15, 2, 8 p., R31.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 6090964